妊娠期高血压疾病的发病机制、临床治疗 与护理对策研究进展
Research Progress on Pathogenesis, Clinical Treatment and Nursing Countermeasures of Hypertensive Disorders of Pregnancy
摘要: 妊娠期高血压疾病是妊娠期特有的、严重威胁母婴安全的并发症,也是导致孕产妇和围生儿死亡的重要原因之一。近年来,随着发病机制研究的深入、诊疗指南的更新、护理模式的创新,在风险预警、药物治疗、综合干预、全程管理等方面取得了许多进展。本文结合国内外最新研究和临床指南,对妊娠期高血压的发病机制、临床治疗、专科护理等方面的研究进展进行综述,旨在为临床实践中优化诊疗、护理方案、改善母婴结局提供循证参考。
Abstract: Hypertensive disorders of pregnancy is a pregnancy-specific complication that seriously threatens the safety of mothers and infants, and it is also one of the important causes of maternal and perinatal deaths. In recent years, with the deepening of pathogenesis research, the update of diagnosis and treatment guidelines, and the innovation of nursing models, many advances have been made in risk warning, drug treatment, comprehensive intervention, and whole-process management. Based on the latest research and clinical guidelines at home and abroad, this article reviews the research progress in the pathogenesis, clinical treatment, and specialized nursing of gestational hypertension, aiming to provide evidence-based reference for optimizing diagnosis and treatment, nursing programs, and improving maternal and infant outcomes in clinical practice.
文章引用:鲁佳, 庞宝华. 妊娠期高血压疾病的发病机制、临床治疗 与护理对策研究进展[J]. 临床医学进展, 2026, 16(5): 2304-2314. https://doi.org/10.12677/acm.2026.1652041

参考文献

[1] 冯晓倩, 邸平, 李芮冰, 等. 凝血指标和尿蛋白对子痫前期及其严重程度的辅助诊断[J]. 安徽医科大学学报, 2026, 61(2): 309-314.
[2] 晁冰迪, 谢禄美, 漆洪波, 等. 从不同指南解析妊娠期高血压疾病的诊治筛防[J]. 实用妇产科杂志, 2022, 38(12): 906-908.
[3] Redman, C.W.G. and Sargent, I.L. (2009) Placental Stress and Pre-Eclampsia: A Revised View. Placenta, 30, 38-42. [Google Scholar] [CrossRef] [PubMed]
[4] Turco, M.Y., Gardner, L., Kay, R.G., Hamilton, R.S., Prater, M., Hollinshead, M.S., et al. (2018) Trophoblast Organoids as a Model for Maternal-Fetal Interactions during Human Placentation. Nature, 564, 263-267. [Google Scholar] [CrossRef] [PubMed]
[5] Tomimatsu, T., Mimura, K., Endo, M., Kumasawa, K. and Kimura, T. (2017) Pathophysiology of Preeclampsia: An Angiogenic Imbalance and Long-Lasting Systemic Vascular Dysfunction. Hypertension Research, 40, 305-310. [Google Scholar] [CrossRef] [PubMed]
[6] Staff, A.C. (2019) The Two-Stage Placental Model of Preeclampsia: An Update. Journal of Reproductive Immunology, 134, 1-10. [Google Scholar] [CrossRef] [PubMed]
[7] Darmochwal-Kolarz, D., Kludka-Sternik, M., Tabarkiewicz, J., Kolarz, B., Rolinski, J., Leszczynska-Gorzelak, B., et al. (2012) The Predominance of Th17 Lymphocytes and Decreased Number and Function of Treg Cells in Preeclampsia. Journal of Reproductive Immunology, 93, 75-81. [Google Scholar] [CrossRef] [PubMed]
[8] Kondělková, K., Vokurková, D., Krejsek, J., Borská, L., Fiala, Z. and Andrýs, C. (2010) Regulatory T Cells (Treg) and Their Roles in Immune System with Respect to Immunopathological Disorders. Acta Medica (Hradec Kralove, Czech Republic), 53, 73-77. [Google Scholar] [CrossRef] [PubMed]
[9] Deer, E., Herrock, O., Campbell, N., Cornelius, D., Fitzgerald, S., Amaral, L.M., et al. (2023) The Role of Immune Cells and Mediators in Preeclampsia. Nature Reviews Nephrology, 19, 257-270. [Google Scholar] [CrossRef] [PubMed]
[10] 宋莉洁. 叶酸代谢相关酶基因多态性与妊娠期糖尿病, 妊娠期高血压及不同妊娠结局的相关性[J]. 实用医技杂志, 2026, 33(3): 204-209.
[11] Li, L., Zhang, Y., Truong, B., Yu, Z., Marston, N., Gupta, R., et al. (2025) Abstract 4359963: Endothelial Susceptibility-Related Genetic Variants and Hypertensive Disorders of Pregnancy. Circulation, 152, A4359963. [Google Scholar] [CrossRef
[12] 吕思晨, 范建霞. 妊娠期高血压疾病对心血管代谢的长期影响管理策略[J]. 实用妇产科杂志, 2025, 41(11): 895-897.
[13] 马玲, 孙勉, 李柯剑, 等. 胰岛素抵抗对胎盘功能影响的研究进展[J]. 妇儿健康导刊, 2026, 5(3): 21-24.
[14] 郑秀霞, 史亚楠, 袁铭, 等. Mthfr基因多态性与同型半胱氨酸水平对孕妇妊娠期高血压疾病发病协同影响的研究[J]. 实用妇产科杂志, 2022, 38(5): 380-383.
[15] 孙晓敏, 吕振楠, 王翠秀. 基于肠道菌群及其代谢产物的子痫前期的研究进展[J]. 中国妇产科临床杂志, 2024, 25(2): 185-187.
[16] 杨嘉妮, 杨琪, 罗晓琪, 等. 铁调素在子痫前期中的研究进展[J]. 中国细胞生物学学报, 2026, 48(2): 546-554.
[17] 陈炳南, 乔宠. 细胞间通信异常在子痫前期发病机制中的作用[J]. 中国医科大学学报, 2026, 55(2): 97-102.
[18] 张跃辉, 朱小琳, 朱锦明, 等. 子痫前期中医诊疗指南(2025版) [J/OL]. 中国实验方剂学杂志, 2025: 1-16.
https://kns.cnki.net/kcms2/article/abstract?v=bKzrHQijxWZxRTTZsCqLXIYsnUyR1olmVDoRcdQcf6isalRDvTlvjw6reL4bJxM-mkEkqTNkN_S2JKHMVyvMshTSmyJMvLD9GRISTbN3I1ZqxFLgd5kE8xSmLOC51j05XA-HNYPzDEqBm5xShpq3ARVk9dU24wzFNDaiCDxqcAccxYt586Jviw==&uniplatform=NZKPT&language=CHS, 2025-11-17.
[19] Chaemsaithong, P., Sahota, D.S. and Poon, L.C. (2022) First Trimester Preeclampsia Screening and Prediction. American Journal of Obstetrics and Gynecology, 226, S1071-S1097.e2. [Google Scholar] [CrossRef] [PubMed]
[20] Rosenberg, E.A. and Seely, E.W. (2024) Update on Preeclampsia and Hypertensive Disorders of Pregnancy. Endocrinology and Metabolism Clinics of North America, 53, 377-389. [Google Scholar] [CrossRef] [PubMed]
[21] 刘璐, 史晓霞, 高亚楠, 等. 孕前体重指数对阿司匹林预防子痫前期最佳给药剂量影响的真实世界研究[J]. 实用药物与临床, 2026, 29(1): 37-42.
[22] Afolabi, B.B., Babah, O.A., Oshodi, Y.A., et al. (2026) Low-Dose Aspirin for Preventing Intrauterine Growth Restriction and Pre-Eclampsia in Sickle Cell Pregnancy in Nigeria (PIPSICKLE): A Randomised Controlled Trial. The Lancet Global Health, 14, e386-e394.
[23] Meher, S., Maher, A., Brocklehurst, P., Chappell, L., Ewer, A., Green, M., et al. (2026) Calcium Supplementation for Prevention of Pre-Eclampsia in High-Risk Women: Study Protocol for a Randomised Triple-Blind Placebo-Controlled Trial (CaPE). Trials, 27, Article No. 321. [Google Scholar] [CrossRef
[24] 中华医学会妇产科学分会妊娠期高血压疾病学组. 子痫前期预测与预防指南(2025) [J]. 中华妇产科杂志, 2025, 60(5): 329-342.
[25] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志, 2020, 55(4): 227-238.
[26] Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstetrics and Gynecology, 135, 1492-1495.
[27] Magee, L.A., Brown, M.A., Hall, D.R., Gupte, S., Hennessy, A., Karumanchi, S.A., et al. (2022) The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice. Pregnancy Hypertension, 27, 148-169. [Google Scholar] [CrossRef] [PubMed]
[28] Regitz-Zagrosek, V., Roos-Hesselink, J.W., Bauersachs, J., Blomstrom-Lundqvist, C., Cifkova, R., De Bonis, M., et al. (2019) 2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy. Kardiologia Polska, 77, 245-326. [Google Scholar] [CrossRef] [PubMed]
[29] 蔡海瑞, 陈安儿. 拉贝洛尔和硝苯地平治疗子痫前期患者的临床研究[J]. 中国临床药理学杂志, 2025, 41(17): 2435-2440.
[30] McCoy, S. and Baldwin, K. (2009) Pharmacotherapeutic Options for the Treatment of Preeclampsia. American Journal of Health-System Pharmacy, 66, 337-344. [Google Scholar] [CrossRef] [PubMed]
[31] Robinson, A.A., Curl, O., Mandelbaum, A., Doshi, U., Caughey, A.B. and Penfield, C.A. (2026) 12 versus 24 Hours of Postpartum Magnesium Sulfate for Seizure Prophylaxis: A Cost-Effectiveness Analysis. American Journal of Obstetrics & Gynecology MFM, 8, Article 101819. [Google Scholar] [CrossRef
[32] Alves de Melo Silva, M.L., Custódio, P.G., Costa, M.L., Surita, F.D.C. and Guida, J.P.D.S. (2025) A 12-Hour versus 24-Hour Magnesium Sulfate Intravenous Regimen in Postpartum Women with Preeclampsia: A Randomized Clinical Trial. Pregnancy Hypertension, 42, Article 101391. [Google Scholar] [CrossRef
[33] Carter, S.W.D., Benetti, A.A., Sia, R.T.L., Pastorin, G., Johnson, E.L., Seah, K.Y.M., et al. (2025) Transdermal Delivery of Antenatal Steroids to Promote Fetal Lung Maturation: Proof of Principle Data from Sheep and Non-Human Primate Models. BMC Medicine, 23, Article No. 452. [Google Scholar] [CrossRef] [PubMed]
[34] Li, K., Jia, X., Guo, D., Wang, H., Shui, H., Qi, H., et al. (2025) CGKRK-Targeted Lipid Nanoparticles Enhance in Vivo Rosiglitazone Delivery to the Placenta to Ameliorate Murine Preeclampsia. iScience, 28, Article 112744. [Google Scholar] [CrossRef] [PubMed]
[35] Cluver, C.A., Thake, J., Hassim, T., van Greunen, A., Budhram, S., Knipe, K., et al. (2025) Safety and Potential Efficacy of DM199, a Tissue Kallikrein-1 Analogue, for Treating Pre-Eclampsia and Fetal Growth Restriction: Study Protocol for a South African, Hospital-Based Phase I/II Open-Label Trial. BMJ Open, 15, e104035. [Google Scholar] [CrossRef
[36] Abdalla, R.A.H., Parveen, N., Iqbal, N., Mohamed, A.A.A., Shahid, S.M.A., Elhussein, G.E.M.O., et al. (2025) Adipokines in Preeclampsia: Disrupted Signaling Pathways and Novel Therapeutic Strategies. European Journal of Medical Research, 30, Article No. 702. [Google Scholar] [CrossRef] [PubMed]
[37] Luque, N.M., Leader, L., Lowe, S.M., Horrowitz, S.D., Tare, M., Hinkley, V., et al. (2026) Pravastatin Corrects Endothelial Dysfunction in Ex Vivo Uterine Radial Arteries in Preeclampsia. Acta Physiologica, 242, e70186. [Google Scholar] [CrossRef
[38] Lou, Y., Chen, Y., Chen, L., Yang, T. and He, L. (2025) Novel Molecular Strategies for Preeclampsia Management: A Pathophysiological and Therapeutic Perspective. Hypertension in Pregnancy, 44, Article 2540285. [Google Scholar] [CrossRef] [PubMed]
[39] Robbins, M.K., Nembaware, H., Mandal, S., Bhopatkar, A., Parker, A., Chambers, C., et al. (2026) Hypertensive Pregnancy Disorders: From Mechanisms to Management. American Journal of Hypertension, 39, 3-14. [Google Scholar] [CrossRef] [PubMed]
[40] 林晓宇, 孙远远, 孔欣. 星状神经节埋线治疗原发性高血压的作用机制[J]. 中国当代医药, 2026, 33(2): 193-198.
[41] 吴娜, 冯晶晶, 李苑瑛. 早发型子痫前期患者妊娠压力的影响因素[J]. 中国民康医学, 2026, 38(8): 44-47.
[42] 黄丽华, 翟巾帼, 田金徽, 等. 妊娠期生活方式干预对妊娠期高血压疾病进展及母婴结局影响的Meta分析[J]. 护理学报, 2023, 30(24): 38-42.
[43] Xu, Y., Zhu, S., Song, H., Lian, X., Zeng, M., He, J., et al. (2022) A New Modified Obstetric Early Warning Score for Prognostication of Severe Maternal Morbidity. BMC Pregnancy and Childbirth, 22, Article No. 901. [Google Scholar] [CrossRef] [PubMed]
[44] Xu, W., Xing, C., Chen, C., Huang, Y., Li, P. and Zhai, J. (2026) Efficacy of an E-Education Program Based on the Health Belief Model on Exercise Management in Women with Gestational Hypertension: A Randomized Controlled Clinical Trial. International Journal of Nursing Sciences, 13, 19-26. [Google Scholar] [CrossRef
[45] 蒲丛珊, 单春剑, 张翔娣, 等. 共享护理门诊在妊娠期高血压疾病患者中的应用研究[J]. 中华护理杂志, 2025, 60(14): 1669-1676.
[46] 袁国香, 唐乐, 李晓红, 刘荣, 高滢侠. 多学科协同护理模式对妊娠高血压患者血压水平及分娩结局的影响[J]. 国际医药卫生导报, 2025, 31(18): 3112-3117.
[47] McCabe, M., Lemon, L., Kalchthaler, F., Hauspurg, A. and Countouris, M. (2025) Impact of a Multidisciplinary Postpartum Hypertension Clinic on Cardiovascular Risk Factor Screening and Engagement in Postpartum Care after Hypertensive Disorder of Pregnancy. Journal of the American College of Cardiology, 85, Article 2645. [Google Scholar] [CrossRef
[48] Addo, K.M., Khan, H.T.A. and Ohl, M. (2025) Association between Hypertensive Disorders of Pregnancy and Postpartum Depression: A Study on Low-and Middle-Income Countries with Insights from Ghanaian Healthcare Professionals. Journal of Biosocial Science, 57, 429-448. [Google Scholar] [CrossRef] [PubMed]
[49] Aryunani, A., Qomaruddin, M.B., Prasetyo, B., Nuzula, F. and Mardliyana, N.E. (2026) Effectiveness of Non-Pharmacological Treatments in Lowering Blood Pressure in Pregnant Women with Hypertension: A Systematic Review. African Journal of Reproductive Health, 30, 124-138. [Google Scholar] [CrossRef
[50] 刘轩田, 冉雪荣, 翟巾帼. 基于潜在剖面分析的妊娠期高血压患者疾病知识水平及其与自我管理能力的关系[J]. 军事护理, 2026, 43(3): 17-21.
[51] Jongsma, K.R., van den Heuvel, J.F.M., Rake, J., Bredenoord, A.L. and Bekker, M.N. (2020) User Experiences with and Recommendations for Mobile Health Technology for Hypertensive Disorders of Pregnancy: Mixed Methods Study. JMIR mHealth and uHealth, 8, e17271. [Google Scholar] [CrossRef] [PubMed]
[52] Aguiar, T.F., Nobre dos Santos, J.A., Gonzaga, A., Garcia, A., Santos, R., Ribeiro, J., et al. (2026) Remote Blood Pressure Telemonitoring in Hypertensive Pregnancies: Feasibility and Preliminary Outcomes from a Regional Program. Pregnancy Hypertension, 44, Article 101451. [Google Scholar] [CrossRef
[53] Zapata, R.D., Tolani, T., Reich, R., Beneteau, S., Ali, H., Kolli, T., et al. (2025) AI in Hypertensive Disorders of Pregnancy: Review. American Journal of Hypertension, 38, 1009-1019. [Google Scholar] [CrossRef] [PubMed]
[54] 韩秀红, 张超, 邱忠君. 穴位按摩联合心理干预对妊娠期高血压病人血压、心理及妊娠结局的影响[J]. 护理研究, 2020, 34(8): 1439-1442.
[55] 陈纪烨, 滑振, 朱羽硕, 等. 难治性高血压中西医结合诊疗专家共识[J/OL]. 中国实验方剂学杂志, 2025: 1-12.
https://kns.cnki.net/kcms2/article/abstract?v=bKzrHQijxWZrvZvmrXQkSwtAVgAQsI0B_laGbeiulIeRBYTYkCMySo2pZwej54dZB9urYMnVjbj9zVjVwSNLlG3WZ-r0mj2VciXmHCsvvx4A-Sk6FBR292Aeo_TUClxKUrTHlJhDEv_U74CGmv2vDvIsWSmrqP6uV9YtXS-2vOvEidN_GFBOtg==&uniplatform=NZKPT&language=CHS, 2025-11-11.
[56] Keshtkar, L., Ranjkesh, F., Habibi, M. and Rashvand, F. (2024) Effects of Auriculotherapy on Gestational Hypertension: Randomized Controlled Trial Study. Iranian Journal of Nursing and Midwifery Research, 29, 40-45. [Google Scholar] [CrossRef] [PubMed]
[57] 樊晋余, 戚婷婷, 曾雯琼. 天麻钩藤饮治疗妊娠期高血压对氧化应激指标及肾素-血管紧张素-醛固酮系统的影响[J]. 辽宁中医杂志, 2026, 53(1): 75-78.
[58] Salvi, S., Mandolini, D., Bloemenkamp, K.W.M., Deneux‐Tharaux, C., Engjom, H.M., Kodan, L.R., et al. (2026) Eclampsia Incidence, Management and Outcomes across Multi‐country Surveillance Cohorts: Individual Participant Data Meta-Analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 1-12. [Google Scholar] [CrossRef
[59] Nadeau, C., Pressman, K., Ellis, L., Nuñez Pellot, C., Swope, A., Young, A., et al. (2026) Early Outcomes of an Extended Postpartum Hypertension Program. JACC: Case Reports, 31, Article 106597. [Google Scholar] [CrossRef
[60] Kókai, L.L., Ó Ceallaigh, D., Wijtzes, A.I., Roeters van Lennep, J.E., Duvekot, J.J., Hagger, M.S., et al. (2025) App-based Physical Activity Intervention among Women with Prior Hypertensive Pregnancy Disorder. JAMA Network Open, 8, e252656. [Google Scholar] [CrossRef] [PubMed]
[61] Queiroz, L.F., Lemos, M., Sales Armstrong, B.B., Łajczak, P., de Castro Martin, G.C., de Castro, L.B., et al. (2026) Association between Hypertensive Disorders of Pregnancy and Long-Term Risk of Cardiomyopathy: A Systematic Review, Pairwise, and Network Meta-Analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 321, Article 115038. [Google Scholar] [CrossRef
[62] 杨宁, 李玉明. 构建女性全生命周期血压管理的“一体化防线” [J/OL]. 中华高血压杂志(中英文), 2026: 1-5.
https://kns.cnki.net/kcms2/article/abstract?v=bKzrHQijxWZFFz-2zKZ_MNFgihx5XbPn6LTCvpHdUC-2dUfGyARQMS33JVFHz5AcomZf365-ZKKM49se0BqMI4IPN1A7r5u_rh4FP6saevrXVTP8rpFUWL9KyioXBz-WRJnSZ5NgquJoT7AFX5VOlDSflaJfljaSD43XUv3bUuTSQ_g-Y9UJBQ==&uniplatform=NZKPT&language=CHS, 2026-03-31.